Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,200
Closed -$981K 2966
2022
Q3
$981K Buy
15,200
+11,400
+300% +$790K ﹤0.01% 1821
2022
Q2
$263K Buy
+3,800
New +$282K ﹤0.01% 2133
2020
Q4
Sell
-200,000
Closed -$13.3M 1496
2020
Q3
$13.3M Buy
+200,000
New +$12.7M 0.1% 307
2017
Q4
Sell
-475,000
Closed -$17.4M 2157
2017
Q3
$17.4M Buy
+475,000
New +$19.2M 0.07% 356

Other funds holding HOLX

Dmitry Balyasny's HOLX Position: Q2 2026 in Review

Dmitry Balyasny sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,722,968 shares — an estimated $357M sold.

Dmitry Balyasny first reported a position in HOLX in Q1 2016 and held it in 29 quarters. The position peaked at $357M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Dmitry Balyasny reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 4,722,968 Hologic shares in Q2 2026, an estimated $357M.
  • Dmitry Balyasny first reported a position in Hologic in Q1 2016 and held it in 29 quarters.
  • Dmitry Balyasny's Hologic position peaked at $357M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.